Amanote Research
Register
Sign In
Antineoplastic Effects of Decitabine, an Inhibitor of DNA Promoter Methylation, in Adrenocortical Carcinoma Cells
Archives of Surgery
doi 10.1001/archsurg.2009.292
Full Text
Open PDF
Abstract
Available in
full text
Date
March 1, 2010
Authors
Insoo Suh
Publisher
American Medical Association (AMA)
Related search
Artesunate-Enhanced Apoptosis of Human High-Risk Myelodysplastic Cells Induced by the DNA Methyltransferase Inhibitor Decitabine
Oncology Letters
Cancer Research
Oncology
Age-Related Changes in DNA Methylation Status of hTERT Gene Promoter of Oral Epithelial Cells
Brazilian Archives of Biology and Technology
Detection of Methylation Status of Epstein ‐ Barr Virus DNA C ‐ Promoter in the Diagnosis of Nasopharyngeal Carcinoma
Cancer Science
Cancer Research
Medicine
Oncology
A Critical Re-Assessment of DNA Repair Gene Promoter Methylation in Non-Small Cell Lung Carcinoma
Scientific Reports
Multidisciplinary
Clinical Significance of Aberrant DEUP1 Promoter Methylation in Hepatocellular Carcinoma
Oncology Letters
Cancer Research
Oncology
Evaluation of MYB Promoter Methylation in Salivary Adenoid Cystic Carcinoma
Oral Oncology
Cancer Research
Oral Surgery
Oncology
Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma
Asian Pacific Journal of Cancer Prevention
Effect of an Inhibitor of DNA Methylation on T Cells. II. 5-Azacytidine Induces Self-Reactivity in Antigen-Specific T4+ Cells
Human Immunology
Medicine
Allergy
Immunology
Synergistic Antineoplastic Action of 5-Aza-2'deoxycytidine (Decitabine) in Combination With Different Inhibitors of Enhancer of Zeste Homolog 2 (EZH2) on Human Lung Carcinoma Cells
Journal of Cancer Research & Therapy
